Brief: Portage Biotech Announces First Patient Dosed In Phase 1A Trial Of PORT-6 In Select Solid Tumors
26/06/2023 13:20
June 26 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH ANNOUNCES FIRST PATIENT DOSED IN PHASE 1A
TRIAL
OF PORT-6 IN SELECT SOLID TUMORS
Source text for Eikon: ID:nGNX9pGXyK
Further company coverage: PRTG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsBrief: Alpha Compute Corp. Provides Mid-Q2 2026 Update
Brief: Alpha Compute Ai Gpu Launch Update First Large-Scale Nvidia Blackwell Cluster
Brief: Alpha Compute Appoints Tom Richer To Advisory Board To Accelerate Ai Gpu Compute Infrastructure And Confidential Cloud Strategy
Brief: Alphaton Capital Rebrands As Alpha Compute Corp. To Reflect Its Growing Ai Compute Business
Brief: Alphaton Capital Announces $43 Million Ai Infrastructure And Financing Partnership With Vertical Data